Organization
Mitsubishi Tanabe Pharma Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Mitsubishi Tanabe Pharma Corp.
... split ACQUISITIONS AND MERGERS MINIMUM VALUE $100 MILLION Neuroderm Ltd - Mitsubishi Tanabe Pharma Corp (1.1B) Sciclone Pharmaceuticals Inc - Silver Biotech Investment (605M) NEW ...
... Corporation (hereinafter, 'MTPC') completed the transfer of all shares of Tanabe Seiyaku Hanbai Co., Ltd. (hereinafter, 'TSH') to Nipro Corporation (hereinafter, 'Nipro') as scheduled on ...
... and Forecast report entitledOsteoarthritic Pain: Anti-NGF therapies from Pfizer/Eli Lilly and Regeneron/Teva/Mitsubishi Tanabe Pharma will account for nearly three-quarters of major-market osteoarthritic pain sales in ...
... Viceroy Research (Viceroy) today released a detailed analysis of Mitsubishi Tanabe's (TYO: 4508) potential acquisition of Neuroderm (NASDAQ: NDRM). Viceroy has meticulously ...
... of INGREZZA in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe). Mitsubishi Tanabe expects to initiate a pivotal trial of ...
... billion losses. Neuroderm – Neuroderm agreed to be bought by Japan's Mitsubishi Tanabe Pharma for $1.1 billion in cash. Neuroderm is a drug company based ...
... Mitsubishi Tanabe is to spend $1.1 billion on Parkinson’s disease biotech NeuroDerm as ...
... Innovations LLC , iX Biopharma Ltd , Mezzion Pharma Co Ltd, Mitsubishi Tanabe Pharma Corp , Monosol Rx LLC , N4 Pharma Plc , NAL ...
... Pharmaceuticals Ltd - Mundipharma International Ltd - Monosol Rx LLC - Mitsubishi Tanabe Pharma Corp - Merck & Co Inc - Medy-Tox Inc - Medifron ...
... MedImmune LLC, Merck KGaA, Meta-IQ ApS, Mitochon Pharmaceuticals Inc, Mitotech SA, Mitsubishi Tanabe Pharma Corp, Mochida Pharmaceutical Co Ltd, MorphoSys AG, Mount Tam Biotechnologies Inc, ...
... Luye Pharma Group Ltd, Mapi Pharma Ltd, Merck & Co Inc, Mitsubishi Tanabe Pharma Corp, Neurocrine Biosciences Inc, NeurOp Inc, Newron Pharmaceuticals SpA, Omeros Corp, ...
... rejecting the drug. ( PharmaTimes ) 2. The FDA approved Radicava, Mitsubishi Tanabe Pharma's treatment for amyotrophic lateral sclerosis. It's the first approval of a ...
... Pharmaceuticals - Kamada - King Pharmaceuticals - Medxbio - Merck - Mitsubishi Tanabe Pharma - Novo Nordisk - Novozymes - Portola Pharmaceuticals - ProMetic Life ...
... - NGM Biopharmaceuticals - Neuraltus Pharmaceuticals - Neothetics - Mylan - Mitsubishi Tanabe Pharma - Metabolic Solutions Development - Merz Pharmaceuticals - Merrion Pharmaceuticals - ...
... Johnson - Kyowa Hakko Kirin - Mallinckrodt Pharmaceuticals - Menarini - Mitsubishi Tanabe Pharma - Mylan - Novo Nordisk - Otsuka - Shire - STADA ...
... the influenza vaccine market. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza ...
... Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, ...
... drug classes. Several other companies such as Daiichi Sankyo, Janssen, Merck, Mitsubishi Tanabe Pharma, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda and Zealand Pharma have invested ...
... of those covered by a previously announced collaboration agreement between Regeneron and Mitsubishi, Teva will be responsible for development and commercialization and pay Regeneron a ...
... Sun Pharma announces distribution agreement with Mitsubishi Tanabe ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤